|
End-of-day quote
Egyptian Exchange
2026-10-22
|
5-day change | 1st Jan Change | ||
| 266.51 EGP | -0.93% |
|
-2.82% | +165.92% |
| Market Cap | 13.33B 241M 215M 199M 180M 337M 22.87B 343M 2.39B 947M 11.98B 904M 885M 37.79B | P/E 2025 |
11.7x | P/E 2026 | 32x |
|---|---|---|---|---|---|
| Enterprise Value | 14.86B 269M 240M 222M 201M 376M 25.51B 382M 2.67B 1.06B 13.37B 1.01B 987M 42.14B | EV / Sales 2025 |
1.89x | EV / Sales 2026 | 4.56x |
| Free-Float |
20.38% | Yield 2025 |
4.1% | Yield 2026 | - |
| 1 day | -0.93% | ||
| 1 week | -2.82% | ||
| Current month | -15.66% | ||
| 1 month | -19.97% | ||
| 3 months | +12.92% | ||
| 6 months | +110.81% | ||
| Current year | +165.92% |
| 1 week | 230.01 |  | 302.13 |
| 1 month | 230.01 | | 341 |
| Current year | 87 | | 516.96 |
| 1 year | 87 | | 516.96 |
| 3 years | 41.3 | | 516.96 |
| 5 years | 24 | | 516.96 |
| 10 years | 8.36 | | 516.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Chairman | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.93% | -2.82% | +95.96% | +388.20% | 241M | |
| -2.54% | +1.31% | +55.10% | +120.84% | 1,135B | |
| -1.42% | +3.23% | +37.07% | +74.26% | 636B | |
| +0.16% | +0.08% | +25.14% | +97.36% | 505B | |
| -0.31% | +3.09% | +43.92% | +64.55% | 378B | |
| -1.34% | -0.47% | +66.63% | +40.56% | 358B | |
| -0.68% | +2.65% | +22.46% | +51.48% | 295B | |
| -1.20% | +3.04% | +2.62% | +26.97% | 266B | |
| -1.79% | +1.57% | +49.97% | +60.87% | 237B | |
| -0.73% | -0.10% | +29.24% | +101.19% | 193B | |
| Average | -0.69% | +2.54% | +42.81% | +102.63% | 400.46B | |
| Weighted average by Cap. | -0.26% | +2.66% | +41.00% | +82.15% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.29B 23.32M 20.82M 19.24M 17.43M 32.62M 2.21B 33.16M 232M 91.65M 1.16B 87.52M 85.66M 3.66B | 2.13B 38.59M 34.46M 31.83M 28.85M 53.97M 3.66B 54.87M 383M 152M 1.92B 145M 142M 6.05B |
| Net income | 126M 2.27M 2.03M 1.88M 1.7M 3.18M 216M 3.23M 22.57M 8.94M 113M 8.53M 8.35M 357M | 256M 4.64M 4.14M 3.82M 3.47M 6.48M 440M 6.59M 46.02M 18.22M 231M 17.4M 17.03M 727M |
| Net Debt | 967M 17.49M 15.62M 14.43M 13.08M 24.47M 1.66B 24.87M 174M 68.75M 870M 65.65M 64.25M 2.74B | 1.54B 27.8M 24.82M 22.93M 20.78M 38.88M 2.64B 39.52M 276M 109M 1.38B 104M 102M 4.36B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-22 | EGP 266.51 | -0.93% | 254,662 |
| 26-10-21 | EGP 269.00 | -4.85% | 280,448 |
| 26-10-20 | EGP 282.70 | -4.51% | 588,954 |
| 26-10-19 | EGP 296.06 | +17.59% | 1,228,921 |
| 26-10-18 | EGP 251.78 | -8.19% | 348,506 |
- Stock Market
- Stocks
- NIPH Stock
Select your edition
All financial news and data tailored to specific country editions
